|
DCAF10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.01819999951547E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.37809999984407E-07 |
| Normal-vs-Stage2 |
2.243700E-03 |
| Normal-vs-Stage3 |
3.123000E-03 |
| Normal-vs-Stage4 |
1.872390E-02 |
| Stage1-vs-Stage2 |
9.259800E-01 |
| Stage1-vs-Stage3 |
9.936400E-01 |
| Stage1-vs-Stage4 |
7.167600E-01 |
| Stage2-vs-Stage3 |
9.332400E-01 |
| Stage2-vs-Stage4 |
7.773800E-01 |
| Stage3-vs-Stage4 |
7.464000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43740000002612E-06 |
| Normal-vs-AfricanAmerican |
9.88520000000381E-05 |
| Normal-vs-Asian |
2.443400E-04 |
| Caucasian-vs-AfricanAmerican |
7.751200E-01 |
| Caucasian-vs-Asian |
3.349000E-01 |
| AfricanAmerican-vs-Asian |
1.801590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83529999975285E-07 |
| Normal-vs-Female |
7.075100E-03 |
| Male-vs-Female |
9.354100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.37210000000521E-05 |
| Normal-vs-Extreme_Weight |
1.20709999995583E-07 |
| Normal-vs-Obese |
4.416400E-03 |
| Normal-vs-Extreme_Obese |
4.286500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.707000E-01 |
| Normal_Weight-vs-Obese |
2.084000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.479400E-01 |
| Extreme_Weight-vs-Obese |
7.062400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.148800E-01 |
| Obese-vs-Extreme_Obese |
6.651600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.178600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.184700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.04509999993208E-07 |
| Normal-vs-Age(81-100Yrs) |
6.116300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.510000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.145000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.263800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.050570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.442400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.077000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.1505999999949E-05 |
| Normal-VS-Type2 PRCC |
8.53530000011204E-07 |
| Normal-VS-KIRP CIMP |
7.417800E-01 |
| Normal-VS-Unclassified PRCC |
6.275900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.262620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.329000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.285800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.488200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.070600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.018600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06079999731656E-08 |
| Normal-vs-N1 |
3.750200E-01 |
| Normal-vs-N2 |
2.23359999999007E-05 |
| N0-vs-N1 |
1.353250E-01 |
| N0-vs-N2 |
2.729800E-01 |
| N1-vs-N2 |
1.237670E-02 |
|
|
